home / stock / cool:cc / cool:cc news

COOL:CC News and Press, Core One Labs Inc.

Stock Information
Company Name: Core One Labs Inc.
Stock Symbol: COOL:CC
Market: CNQC
Menu
COOL:CC COOL:CC Quote COOL:CC Short COOL:CC News COOL:CC Articles COOL:CC Message Board
Get COOL:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
COOL:CC - Canadian Companies Moving the Markets, Evening edition
Mon, Jul 15, 2024 as of 4:00 pm ET

A look at the top 10 most actives in Canada Canadian Natural Resources Limited (CNQ) rose 2.3% to $50.13 on volume of 15,553,477 shares BetaPro Natural Gas Leveraged Daily Bull ETF (HNU) fell 11.5% to $2.93 on volume of 12,773,153 shares Toronto-Dominion Bank (The) (TD) rose 1.2% to $78.2...
COOL:CC - Canadian Companies Moving the Markets, Morning edition
Tue, Jul 09, 2024 as of 10.00 am ET

A look at the top 10 most actives in Canada Toronto-Dominion Bank (The) (TD) fell 0.2% to $75.74 on volume of 4,685,284 shares National Bank of Canada (NA) rose 0.6% to $111.12 on volume of 2,077,722 shares Ascot Resources Ltd. (AOT) fell 10.5% to $0.425 on volume of 1,863,902 shares Br...

COOL:CC - Core One Enters into Loan Agreement with Right Season Investments

VANCOUVER, BC / ACCESSWIRE / July 8, 2024 / Core One Labs Inc. (CSE: COOL )(OTCQB: CLABF )(Frankfurt: LD6 , WKN: A3CSSU ) (the " Company " or " Core One "), is pleased to announce that it has entered into a loan agreement (the " Loan Agreement ") with Right Season Investments Corp. (" Right S...

COOL:CC - Core One Labs Inc. Announces Initial Agreement for Potential Sale of Proprietary Biosynthetic Psilocybin, Facilitating Entry into the International Market

VANCOUVER, BC / ACCESSWIRE / December 8, 2023 / Core One Labs Inc. (CSE: COOL )(OTCQB: CLABF )(Frankfurt: LD6 ) (WKN:A3CSSU) (the " Company " or " Core One ") is pleased to announce the signing of an Initial Agreement (the " Agreement ") with Cube Psytech Corp. (" Cube Psytech ") marking a sig...
COOL:CC - Core One Labs' Akome Reveals Impressive Results for its Psychedelic Bio-Compounds Designed to Target Alzheimer's and Parkinson's, Showing Potential to Outperform Current Treatment Methods

VANCOUVER, BC / ACCESSWIRE / December 1, 2023 / Core One Labs Inc. (" Core One " or the " Company ") (CNSX: COOL )(OTCQB: CLABF )(Frankfurt: LD6 ) (WKN: A3CSSU ), an emerging leader in the field of neuroscience and psychedelics, is delighted to share the exciting results of its first round of S...

COOL:CC - Core One's Akome Reveals Groundbreaking Positive Results from its Second Round of Stage 1 Animal Model Studies for Bio-Compounds Targeting Alzheimer's and Parkinson's Disease

VANCOUVER, BC / ACCESSWIRE / August 4, 2023 / Core One Labs Inc. (CSE: COOL ) (OTCQB: CLABF ) (Frankfurt: LD6 , WKN:A3CSSU), (the " Company " or " Core One ") is delighted to announce the receipt of additional positive results from its second round (" Round 2 ") of Stage 1 animal model studies. ...

COOL:CC - Core One Labs', Awakened Biosciences, Announces Groundbreaking Step Forward in Isolating and Purifying Psilocybin from Mushroom Biomass

Core One's Wholly-Owned Subsidiary has filed a patent application with the United States Patent and Trademark Office VANCOUVER, BC / ACCESSWIRE / August 1, 2023 / Core One Labs Inc. (CSE: COOL )(OTCQB: CLABF )(Frankfurt: LD6 , WKN:A3CSSU) (the " Company " or " Core One ") proudly announces a...
COOL:CC - Core One's Akome Receives Positive Preliminary Stage 1 Animal Model Study Results for Bio-Compound Targeting Alzheimer's and Parkinson's Disease

VANCOUVER, BC / ACCESSWIRE / July 28, 2023 / Core One Labs Inc. (CSE: COOL )(OTCQB: CLABF )(Frankfurt: LD6) (WKN:A3CSSU) (the " Company " or " Core One "), is excited to share positive results from its first round of Stage 1 animal model studies (" Round 1"), conducted by its research partners...

COOL:CC - Core One Labs Enters into Letter of Intent for First Sale of Its Psychedelic Compounds

VANCOUVER, BC / ACCESSWIRE / July 21, 2023 / Core One Labs Inc. (CSE: COOL )(OTCQB: CLABF )(Frankfurt: LD6 ) (WKN: A3CSSU) (the " Company " or " Core One ") is pleased to announce that its wholly-owned subsidiary, GMP Drug Inc. (" GMP Drug "), has entered into a non-binding letter of intent ...

COOL:CC - Core One's Vocan Biotechnologies Incorporates New Bioreactor Equipment into Production Process Significantly Increasing Throughput of Proprietary Biosynthetic Psilocybin

VANCOUVER, BC / ACCESSWIRE / July 11, 2023 / Core One Labs Inc. (CSE: COOL ), (OTCQB: CLABF ), (Frankfurt: LD6 , WKN: A3CSSU ) (the " Company ") is pleased to announce that its wholly-owned subsidiary Vocan Biotechnologies Inc. (" Vocan ") has incorporated a state-of-the-art, high density, fer...
Next 10